The value and effectiveness of angiogenesis inhibitors for colorectal cancer

MeSH terms

• Angiogenesis Inhibitors / pharmacology
• Angiogenesis Inhibitors / therapeutic use*
• Antibodies, Monoclonal / pharmacology
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / pharmacology
• Antineoplastic Agents / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bevacizumab / pharmacology
• Bevacizumab / therapeutic use
• Clinical Trials as Topic
• Colorectal Neoplasms / drug therapy*
• Colorectal Neoplasms / pathology
• Drug Approval
• Humans
• Neovascularization, Pathologic / drug therapy
• Phenylurea Compounds / pharmacology
• Phenylurea Compounds / therapeutic use
• Pyridines / pharmacology
• Pyridines / therapeutic use
• Ramucirumab
• Receptors, Vascular Endothelial Growth Factor / pharmacology
• Receptors, Vascular Endothelial Growth Factor / therapeutic use
• Recombinant Fusion Proteins / pharmacology
• Recombinant Fusion Proteins / therapeutic use
• Treatment Outcome
• United States
• United States Food and Drug Administration